Cargando…
miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in silico” predic...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903605/ https://www.ncbi.nlm.nih.gov/pubmed/24475217 http://dx.doi.org/10.1371/journal.pone.0087039 |
_version_ | 1782301120406749184 |
---|---|
author | Crippa, Elisabetta Lusa, Lara De Cecco, Loris Marchesi, Edoardo Calin, George Adrian Radice, Paolo Manoukian, Siranoush Peissel, Bernard Daidone, Maria Grazia Gariboldi, Manuela Pierotti, Marco Alessandro |
author_facet | Crippa, Elisabetta Lusa, Lara De Cecco, Loris Marchesi, Edoardo Calin, George Adrian Radice, Paolo Manoukian, Siranoush Peissel, Bernard Daidone, Maria Grazia Gariboldi, Manuela Pierotti, Marco Alessandro |
author_sort | Crippa, Elisabetta |
collection | PubMed |
description | A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in silico” predicted putative target gene ID4, a transcription factor of the helix-loop-helix protein family whose expression is inversely correlated with that of ER. ID4 is expressed in breast cancer and can negatively regulate BRCA1 expression. Our results showed an inverse correlation between ID4 and miR-342 as well as between ID4 and BRCA1 expression. We functionally validated the interaction between ID4 and miR-342 in a reporter Luciferase system. Based on these findings, we hypothesized that regulation of ID4 mediated by miR-342 could be involved in the pathogenesis of breast cancer by downregulating BRCA1 expression. We functionally demonstrated the interactions between miR-342, ID4 and BRCA1 in a model provided by ER-negative MDA-MB-231 breast cancer cell line that presented high levels of ID4. Overexpression of miR-342 in these cells reduced ID4 and increased BRCA1 expression, supporting a possible role of this mechanism in breast cancer. In the ER-positive MCF7 and in the BRCA1-mutant HCC1937 cell lines miR-342 over-expression only reduced ID4. In the cohort of patients we studied, a correlation between miR-342 and BRCA1 expression was found in the ER-negative cases. As ER-negative cases were mainly BRCA1-mutant, we speculate that the mechanism we demonstrated could be involved in the decreased expression of BRCA1 frequently observed in non BRCA1-mutant breast cancers and could be implicated as a causal factor in part of the familial cases grouped in the heterogeneous class of non BRCA1 or BRCA2-mutant cases (BRCAx). To validate this hypothesis, the study should be extended to a larger cohort of ER-negative cases, including those belonging to the BRCAx class. |
format | Online Article Text |
id | pubmed-3903605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39036052014-01-28 miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer Crippa, Elisabetta Lusa, Lara De Cecco, Loris Marchesi, Edoardo Calin, George Adrian Radice, Paolo Manoukian, Siranoush Peissel, Bernard Daidone, Maria Grazia Gariboldi, Manuela Pierotti, Marco Alessandro PLoS One Research Article A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in silico” predicted putative target gene ID4, a transcription factor of the helix-loop-helix protein family whose expression is inversely correlated with that of ER. ID4 is expressed in breast cancer and can negatively regulate BRCA1 expression. Our results showed an inverse correlation between ID4 and miR-342 as well as between ID4 and BRCA1 expression. We functionally validated the interaction between ID4 and miR-342 in a reporter Luciferase system. Based on these findings, we hypothesized that regulation of ID4 mediated by miR-342 could be involved in the pathogenesis of breast cancer by downregulating BRCA1 expression. We functionally demonstrated the interactions between miR-342, ID4 and BRCA1 in a model provided by ER-negative MDA-MB-231 breast cancer cell line that presented high levels of ID4. Overexpression of miR-342 in these cells reduced ID4 and increased BRCA1 expression, supporting a possible role of this mechanism in breast cancer. In the ER-positive MCF7 and in the BRCA1-mutant HCC1937 cell lines miR-342 over-expression only reduced ID4. In the cohort of patients we studied, a correlation between miR-342 and BRCA1 expression was found in the ER-negative cases. As ER-negative cases were mainly BRCA1-mutant, we speculate that the mechanism we demonstrated could be involved in the decreased expression of BRCA1 frequently observed in non BRCA1-mutant breast cancers and could be implicated as a causal factor in part of the familial cases grouped in the heterogeneous class of non BRCA1 or BRCA2-mutant cases (BRCAx). To validate this hypothesis, the study should be extended to a larger cohort of ER-negative cases, including those belonging to the BRCAx class. Public Library of Science 2014-01-27 /pmc/articles/PMC3903605/ /pubmed/24475217 http://dx.doi.org/10.1371/journal.pone.0087039 Text en © 2014 Crippa et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Crippa, Elisabetta Lusa, Lara De Cecco, Loris Marchesi, Edoardo Calin, George Adrian Radice, Paolo Manoukian, Siranoush Peissel, Bernard Daidone, Maria Grazia Gariboldi, Manuela Pierotti, Marco Alessandro miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer |
title | miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer |
title_full | miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer |
title_fullStr | miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer |
title_full_unstemmed | miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer |
title_short | miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer |
title_sort | mir-342 regulates brca1 expression through modulation of id4 in breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903605/ https://www.ncbi.nlm.nih.gov/pubmed/24475217 http://dx.doi.org/10.1371/journal.pone.0087039 |
work_keys_str_mv | AT crippaelisabetta mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT lusalara mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT dececcoloris mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT marchesiedoardo mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT calingeorgeadrian mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT radicepaolo mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT manoukiansiranoush mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT peisselbernard mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT daidonemariagrazia mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT gariboldimanuela mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer AT pierottimarcoalessandro mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer |